News from ait - advanced inhalation therapies ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 01, 2015, 07:00 ET

Advanced Inhalation Therapies Granted European Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis

Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European Commission, acting on the...

Apr 21, 2015, 07:00 ET

Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings

Advanced Inhalation Therapies Ltd (AIT), a leading anti-viral therapeutic company, announced that two abstracts have been accepted for oral...

Feb 09, 2015, 08:07 ET

Advanced Inhalation Therapies Receives Orphan Drug Designation of its Proprietary High Dose Formulation of Nitric Oxide for Adjunctive Treatment of Cystic Fibrosis

Advanced Inhalation Therapies Ltd (AIT), a leading Nitric Oxide therapeutic company, announced that the U.S. Food and Drug Administration (FDA)...

Feb 10, 2014, 09:13 ET

AIT's Phase II Clinical Trial for Cystic Fibrosis Adds Schneider Children's Medical Center of Israel as Second Site in Expanded Trial

Advanced Inhalation Therapies (AIT Ltd.), a drug development company, announced today it added Schneider Children's Medical Center of Israel as...

Feb 03, 2014, 09:50 ET

AIT To Present NOxCureBR at the Annual Meeting of the Israeli Association of Clinical Pediatrics (Israeli Clinical Pediatric Society 2014)

Advanced Inhalation Therapies (AIT), a leader in the development of nitric oxide (NO) therapeutics for the treatment of infectious respiratory...

Jan 23, 2014, 07:29 ET

AIT To Present Phase II Clinical Data for NOxCureBR, A Treatment for Acute Bronchiolitis and RSV in Infants

Advanced Inhalation Therapies (AIT), a leader in the development of nitric oxide (NO) therapeutics for the treatment of infectious respiratory...

Jan 07, 2014, 10:22 ET

AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation

Advanced Inhalation Therapies (AIT Ltd.), an Israeli drug development company, announced today that it has begun enrollment in Israel for a...

Dec 16, 2013, 07:02 ET

Hannah Blau, M.B.B.S, Joins AIT's Scientific Advisory Board

                 Advanced Inhalation Therapies (AIT), a leader in...

Sep 17, 2013, 07:34 ET

Hugh M. O'Brodovich, M.D., Joins AIT's Scientific Advisory Board

Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development of nitric oxide therapeutics for the treatment of...

Aug 21, 2013, 10:15 ET

AIT Ltd. and Clalit Health Services Expand Strategic Alliance and Plan Phase II Clinical Trial for Respiratory Diseases

   - AIT focuses on treatments for infectious respiratory diseases including, bronchiolitis, cystic fibrosis, and pneumonia....

Aug 07, 2013, 07:28 ET

Andrew R. Colin, M.D., Joins AIT's Scientific Advisory Board

Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development of nitric oxide therapeutics for the treatment of...